In this episode of The BioHub Podcast, Max sits down with Amit Etkin, Founder and CEO of Alto Neuroscience.
Psychiatry is one of the few areas in medicine still dominated by trial and error.
Amit is trying to change that.
A trained psychiatrist and neuroscientist, Amit founded Alto to bring precision medicine into mental health — using biomarkers to better match patients with the treatments that actually work for them.
In this conversation, we get into why CNS drug development has historically struggled, what’s broken in the current system, and how a more data-driven approach could reshape the future of psychiatry.
We also talk about Amit’s journey from academia to founder, the realities of building in a tough market, and why now might finally be the turning point for neuroscience.
A thoughtful, honest conversation tackling one of the hardest problems in medicine. 🧠
